ANP, atrial natriuretic peptide
Pure GLP-1 agonists vs dual agonists: why the distinction matters The receptor target determines the side effect profile, efficacy ceiling, and patient selection criteria
The use of agents increasing GLP-1 receptor signaling may be associated with a neuroprotective effect in Alzheimers disease (AD) by preventing declines in cortical activity, decreasing A-levels and improving cognitive function as well as the volume of gray matter of patients
The Precision Peptide Genetic Test can identify genetic variants affecting GLP-1 receptor responsiveness, helping optimize your personalized therapy
2 Faculty of Medicine, Yarsi University, Jakarta, Indonesia
Hormone therapy remains the most effective option, reducing hot flash frequency by approximately 75%